Metabolic insights to explore mechanisms of pregnancy and early life course health.
Our cord blood biomarker analysis enables assessment of molecular effects related to both infant and maternal metabolism at birth as it allows simultaneous quantification of numerous groups of biomarkers. For instance, it analyses routine lipids, lipoprotein subclass profiling (with lipid concentrations within 14 subclasses), fatty acid composition and various low-molecular metabolites.
The biomarkers come as a package and we provide all listed measurements in the cord blood panel as a bunch. Results are provided in molar concentration units and are therefore ready-to-use.
High-throughput technology allows analysis at competitive pricing. The cost is based on the size and volume of the sample sets. The higher the number of samples, the lower the cost of analysis per sample.
Our cord blood biomarkers can help detect and unveil risks related to pregnancy complications, which can provide potential solutions for prevention and early detection of chronic diseases associated with it. Also, combining findings from cord blood analysis with our blood and urine profiles may reveal modifiable risk factors and targets for early life interventions.
Consult our science team anytime regarding the biomarkers, the platform’s applicability, our analysis process and data results.
Gain from fully quantified biomarker results that are delivered in absolute concentration units. The data comes with detailed description of the quality of the samples to support the reliability and validity of research results.
As an additional service, our in-house data scientists can provide a full data analysis of the results, based on your chosen variants and the focus of your research.
Whether you have a question or you would like to ask for an offer, let us know and we'll get back to you very soon.